Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Advanced Chemotherapy Technologies, a US-based cancer drug delivery spinout of University of North Carolina at Chapel Hill, closed a $5.5m series A round yesterday led by venture capital firm Khosla Ventures. The funding will be used to drive initial clinical development of its technology, targeting certain forms of pancreatic cancer.
SurfactGreen, a France-based surfactant chemical producer, has secured €4.7m ($5.5m) of equity and grant funding from investors including regional tech transfer office Satt Ouest Valorisation. The total includes $1.9m of dilutive funding from Satt Ouest, Go Capital, Finovam Management and unnamed members of SurfactGreen’s team, in addition to $3.6m in subsidies from state-owned investment bank Bpifrance and the French Environment and Energy Management Agency. SurfactGreen produces surfactant materials using sustainable ingredients for applications including construction and cosmetics. Satt Ouest Valorisation backed a $1.3m round for SurfactGreen in 2017 together with the latter’s president Pierre-Yves Divet, Go Capital and seed…
